We Think Foghorn Therapeutics (NASDAQ:FHTX) Needs To Drive Business Growth Carefully [Yahoo! Finance]
Foghorn Therapeutics Inc. (FHTX)
Company Research
Source: Yahoo! Finance
By way of example, Foghorn Therapeutics NASDAQ:FHTX ) has seen its share price rise 156% over the last year, delighting many shareholders. But while history lauds those rare successes, those that fail are often forgotten; who remembers Pets.com? Given its strong share price performance, we think it's worthwhile for Foghorn Therapeutics shareholders to consider whether its cash burn is concerning. In this report, we will consider the company's annual negative free cash flow, henceforth referring to it as the 'cash burn'. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway. See our latest analysis for Foghorn Therapeutics A company's cash runway is calculated by dividing its cash hoard by its cash burn. When Foghorn Therapeutics last reported its September 2024 balance sheet in November 2024, it had zero debt and cash worth US$267m. Looking at the last year, the company burnt through US$104m. So it had a cash runway of about 2.6 year
Show less
Read more
Impact Snapshot
Event Time:
FHTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FHTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FHTX alerts
High impacting Foghorn Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
FHTX
News
- Foghorn Therapeutics Inc. (NASDAQ: FHTX) was upgraded by analysts at B. Riley to a "strong-buy" rating.MarketBeat
- Foghorn Therapeutics Inc. (NASDAQ: FHTX) is now covered by analysts at B. Riley. They set a "buy" rating and a $10.00 price target on the stock.MarketBeat
- Foghorn Therapeutics files for mixed shelf offering [Seeking Alpha]Seeking Alpha
- Flagship Pioneering, Cambridge University Health Partners, and Milner Therapeutics Institute Announce Collaboration to Accelerate Biotech Research and InnovationPR Newswire
- Flagship Pioneering, Cambridge University Health Partners, and Milner Therapeutics Institute Announce Collaboration to Accelerate Biotech Research and InnovationPR Newswire
FHTX
Earnings
- 11/4/24 - Beat
FHTX
Sec Filings
- 2/12/25 - Form SCHEDULE
- 2/3/25 - Form 8-K
- 2/3/25 - Form EFFECT
- FHTX's page on the SEC website